Reported 1 day ago
BrightSpring Health Services, Inc. (NASDAQ:BTSG) has experienced a remarkable 29% year-over-year revenue growth, reaching $3.1 billion in Q2 2025, prompting analysts to raise their price targets significantly. Following a successful earnings call and an increase in guidance for revenue and adjusted EBITDA, both Deutsche Bank and Bank of America adjusted their predictions upwards, while the stock maintains a Buy consensus rating. Since its IPO, BTSG has shown considerable growth, with its stock price increasing by 147.09%.
Source: YAHOO